BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gunnarsson R, Staaf J, Jansson M, Ottesen AM, Göransson H, Liljedahl U, Ralfkiaer U, Mansouri M, Buhl AM, Smedby KE. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer. 2008;47:697-711. [PMID: 18484635 DOI: 10.1002/gcc.20575] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Sutton L, Rosenquist R. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia. Seminars in Cancer Biology 2015;34:22-35. [DOI: 10.1016/j.semcancer.2015.04.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
2 Forsberg LA, Absher D, Dumanski JP. Republished: Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. Postgrad Med J 2013;89:417-26. [PMID: 23781115 DOI: 10.1136/postgradmedj-2012-101322rep] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Bhoi S, Ljungström V, Baliakas P, Mattsson M, Smedby KE, Juliusson G, Rosenquist R, Mansouri L. Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2. Epigenetics 2016;11:449-55. [PMID: 27128508 DOI: 10.1080/15592294.2016.1178432] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
4 Gunnarsson R, Mansouri L, Rosenquist R. Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies. Leuk Lymphoma 2013;54:1583-90. [PMID: 23167608 DOI: 10.3109/10428194.2012.751530] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
5 Geyer FC, Lacroix-Triki M, Colombo PE, Patani N, Gauthier A, Natrajan R, Lambros MB, Khalifeh I, Albarracin C, Orru S, Marchiò C, Sapino A, Mackay A, Weigelt B, Schmitt FC, Wesseling J, Sneige N, Reis-Filho JS. Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. Histopathology 2012;60:E115-30. [PMID: 22486256 DOI: 10.1111/j.1365-2559.2012.04207.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
6 Mansouri L, Grabowski P, Degerman S, Svenson U, Gunnarsson R, Cahill N, Smedby KE, Geisler C, Juliusson G, Roos G, Rosenquist R. Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients. Am J Hematol 2013;88:647-51. [PMID: 23620080 DOI: 10.1002/ajh.23466] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
7 Schweighofer CD, Coombes KR, Majewski T, Barron LL, Lerner S, Sargent RL, O'Brien S, Ferrajoli A, Wierda WG, Czerniak BA, Medeiros LJ, Keating MJ, Abruzzo LV. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes. J Mol Diagn 2013;15:196-209. [PMID: 23273604 DOI: 10.1016/j.jmoldx.2012.09.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
8 Roullet M, Bagg A. The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas. Advances in Anatomic Pathology 2010;17:333-58. [DOI: 10.1097/pap.0b013e3181ec7466] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
9 Fang Z, Xiong Y, Li J, Liu L, Li M, Zhang C, Zhang W, Wan J. Copy-number increase of AURKA in gastric cancers in a Chinese population: a correlation with tumor progression. Med Oncol 2011;28:1017-22. [PMID: 20585902 DOI: 10.1007/s12032-010-9602-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
10 Curtis C, Lynch AG, Dunning MJ, Spiteri I, Marioni JC, Hadfield J, Chin SF, Brenton JD, Tavaré S, Caldas C. The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics 2009;10:588. [PMID: 19995423 DOI: 10.1186/1471-2164-10-588] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 5.6] [Reference Citation Analysis]
11 Hagenkord JM, Chang CC. The rewards and challenges of array-based karyotyping for clinical oncology applications. Leukemia 2009;23:829-33. [DOI: 10.1038/leu.2009.24] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
12 Geyer FC, Lambros MB, Natrajan R, Mehta R, Mackay A, Savage K, Parry S, Ashworth A, Badve S, Reis-filho JS. Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast. Mod Pathol 2010;23:951-60. [DOI: 10.1038/modpathol.2010.82] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
13 Strefford JC. The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications. Br J Haematol 2015;169:14-31. [PMID: 25496136 DOI: 10.1111/bjh.13254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
14 Natrajan R, Wilkerson PM, Marchiò C, Piscuoglio S, Ng CK, Wai P, Lambros MB, Samartzis EP, Dedes KJ, Frankum J, Bajrami I, Kopec A, Mackay A, A'hern R, Fenwick K, Kozarewa I, Hakas J, Mitsopoulos C, Hardisson D, Lord CJ, Kumar-Sinha C, Ashworth A, Weigelt B, Sapino A, Chinnaiyan AM, Maher CA, Reis-Filho JS. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol 2014;232:553-65. [PMID: 24395524 DOI: 10.1002/path.4325] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 8.1] [Reference Citation Analysis]
15 Lacroix-Triki M, Suarez PH, MacKay A, Lambros MB, Natrajan R, Savage K, Geyer FC, Weigelt B, Ashworth A, Reis-Filho JS. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. J Pathol 2010;222:282-98. [PMID: 20815046 DOI: 10.1002/path.2763] [Cited by in Crossref: 114] [Cited by in F6Publishing: 93] [Article Influence: 9.5] [Reference Citation Analysis]
16 Rajan N, Elliott R, Clewes O, Mackay A, Reis-Filho JS, Burn J, Langtry J, Sieber-Blum M, Lord CJ, Ashworth A. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours. Oncogene. 2011;30:4243-4260. [PMID: 21552290 DOI: 10.1038/onc.2011.133] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
17 Puiggros A, Puigdecanet E, Salido M, Ferrer A, Abella E, Gimeno E, Nonell L, Herranz MJ, Galván AB, Rodríguez-Rivera M, Melero C, Pairet S, Bellosillo B, Serrano S, Florensa L, Solé F, Espinet B. Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques? Leuk Lymphoma 2013;54:986-95. [PMID: 22994157 DOI: 10.3109/10428194.2012.731598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
18 Tang Z, Kanagal-Shamanna R, Tang G, Patel K, Medeiros LJ, Toruner GA. Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia. Leuk Res 2021;108:106616. [PMID: 34022744 DOI: 10.1016/j.leukres.2021.106616] [Reference Citation Analysis]
19 Lindgren D, Höglund M, Vallon-Christersson J. Genotyping techniques to address diversity in tumors. Adv Cancer Res 2011;112:151-82. [PMID: 21925304 DOI: 10.1016/B978-0-12-387688-1.00006-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
20 Ding C, Jin S. High-Throughput Methods for SNP Genotyping. In: Komar AA, editor. Single Nucleotide Polymorphisms. Totowa: Humana Press; 2009. pp. 245-54. [DOI: 10.1007/978-1-60327-411-1_16] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
21 Mantripragada KK, Díaz de Ståhl T, Patridge C, Menzel U, Andersson R, Chuzhanova N, Kluwe L, Guha A, Mautner V, Dumanski JP, Upadhyaya M. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array. Genes Chromosomes Cancer 2009;48:897-907. [PMID: 19603524 DOI: 10.1002/gcc.20695] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
22 Vujkovic M, Attiyeh EF, Ries RE, Horn M, Goodman EK, Ding Y, Kavcic M, Alonzo TA, Gerbing RB, Hirsch B, Raimondi S, Gamis AS, Meshinchi S, Aplenc R. Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group. Cancer Genet 2015;208:408-13. [PMID: 26163103 DOI: 10.1016/j.cancergen.2015.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
23 Sellmann L, Carpinteiro A, Nückel H, Scholtysik R, Siemer D, Klein-Hipass L, Kube D, Dürig J, Dührsen U, Stanelle J, Küppers R. p53 protein expression in chronic lymphocytic leukemia. Leuk Lymphoma 2012;53:1282-8. [PMID: 22220854 DOI: 10.3109/10428194.2011.654115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Pirosanto Y, Laseca N, Valera M, Molina A, Moreno-Millán M, Bugno-Poniewierska M, Ross P, Azor P, Demyda-Peyrás S. Screening and detection of chromosomal copy number alterations in the domestic horse using SNP-array genotyping data. Anim Genet 2021;52:431-9. [PMID: 34013628 DOI: 10.1111/age.13077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Göransson H, Edlund K, Rydåker M, Rasmussen M, Winquist J, Ekman S, Bergqvist M, Thomas A, Lambe M, Rosenquist R, Holmberg L, Micke P, Botling J, Isaksson A. Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data. PLoS One 2009;4:e6057. [PMID: 19557126 DOI: 10.1371/journal.pone.0006057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
26 La-Touche S, Lemetre C, Lambros M, Stankiewicz E, Ng CK, Weigelt B, Rajab R, Tinwell B, Corbishley C, Watkin N, Berney D, Reis-Filho JS. DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes. PLoS One 2016;11:e0146740. [PMID: 26901676 DOI: 10.1371/journal.pone.0146740] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
27 Vetro C, Haferlach T, Jeromin S, Stengel A, Zenger M, Nadarajah N, Baer C, Weissmann S, Kern W, Meggendorfer M, Haferlach C. Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses. Br J Haematol 2018;183:47-59. [PMID: 30022491 DOI: 10.1111/bjh.15498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Osterberg L, Levan K, Partheen K, Delle U, Olsson B, Sundfeldt K, Horvath G. Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas. BMC Cancer 2009;9:368. [PMID: 19835627 DOI: 10.1186/1471-2407-9-368] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
29 Staaf J, Lindgren D, Vallon-Christersson J, Isaksson A, Göransson H, Juliusson G, Rosenquist R, Höglund M, Borg A, Ringnér M. Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays. Genome Biol 2008;9:R136. [PMID: 18796136 DOI: 10.1186/gb-2008-9-9-r136] [Cited by in Crossref: 109] [Cited by in F6Publishing: 101] [Article Influence: 7.8] [Reference Citation Analysis]
30 Kay NE, Eckel-Passow JE, Braggio E, Vanwier S, Shanafelt TD, Van Dyke DL, Jelinek DF, Tschumper RC, Kipps T, Byrd JC, Fonseca R. Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy. Cancer Genet Cytogenet 2010;203:161-8. [PMID: 21156228 DOI: 10.1016/j.cancergencyto.2010.09.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
31 McMullan DJ, Bonin M, Hehir-Kwa JY, de Vries BB, Dufke A, Rattenberry E, Steehouwer M, Moruz L, Pfundt R, de Leeuw N, Riess A, Altug-Teber O, Enders H, Singer S, Grasshoff U, Walter M, Walker JM, Lamb CV, Davison EV, Brueton L, Riess O, Veltman JA. Molecular karyotyping of patients with unexplained mental retardation by SNP arrays: a multicenter study. Hum Mutat 2009;30:1082-92. [PMID: 19388127 DOI: 10.1002/humu.21015] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
32 Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, Natrajan R, Geyer FC, van Kouwenhove M, Kreike B, Mackay A, Ashworth A, van de Vijver MJ, Reis-Filho JS. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene. 2010;29:2013-2023. [PMID: 20101236 DOI: 10.1038/onc.2009.489] [Cited by in Crossref: 274] [Cited by in F6Publishing: 248] [Article Influence: 22.8] [Reference Citation Analysis]
33 Parker H, Strefford JC. The mutational signature of chronic lymphocytic leukemia. Biochemical Journal 2016;473:3725-40. [DOI: 10.1042/bcj20160256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Sutton LA, Rosenquist R. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression. Expert Rev Hematol 2015;8:71-8. [PMID: 25345442 DOI: 10.1586/17474086.2015.972930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
35 Shin JH, Ha KY, Jung SH, Chung YJ. Genetic predisposition in degenerative lumbar scoliosis due to the copy number variation. Spine (Phila Pa 1976) 2011;36:1782-93. [PMID: 21587107 DOI: 10.1097/BRS.0b013e318221a65f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
36 Crotwell PL, Hoyme HE. Advances in whole-genome genetic testing: from chromosomes to microarrays. Curr Probl Pediatr Adolesc Health Care 2012;42:47-73. [PMID: 22325474 DOI: 10.1016/j.cppeds.2011.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
37 Kipps TJ. Genomic complexity in chronic lymphocytic leukemia. Blood 2008;112:1550-1550. [DOI: 10.1182/blood-2008-06-156729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
38 Hernandez L, Wilkerson PM, Lambros MB, Campion-Flora A, Rodrigues DN, Gauthier A, Cabral C, Pawar V, Mackay A, A'Hern R, Marchiò C, Palacios J, Natrajan R, Weigelt B, Reis-Filho JS. Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. J Pathol 2012;227:42-52. [PMID: 22252965 DOI: 10.1002/path.3990] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 10.6] [Reference Citation Analysis]
39 Marchiò C, Lambros MB, Gugliotta P, Di Cantogno LV, Botta C, Pasini B, Tan DS, Mackay A, Fenwick K, Tamber N, Bussolati G, Ashworth A, Reis-Filho JS, Sapino A. Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis. J Pathol 2009;219:16-24. [PMID: 19670217 DOI: 10.1002/path.2574] [Cited by in Crossref: 162] [Cited by in F6Publishing: 147] [Article Influence: 12.5] [Reference Citation Analysis]
40 Marchiò C, Iravani M, Natrajan R, Lambros MB, Geyer FC, Savage K, Parry S, Tamber N, Fenwick K, Mackay A, Schmitt FC, Bussolati G, Ellis I, Ashworth A, Sapino A, Reis-Filho JS. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. J Pathol 2009;218:301-15. [PMID: 19479727 DOI: 10.1002/path.2572] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
41 Sellmann L, Scholtysik R, Kreuz M, Cyrull S, Tiacci E, Stanelle J, Carpinteiro A, Nückel H, Boes T, Gesk S, Siebert R, Klein-Hitpass L, Dührsen U, Dürig J, Küppers R. Gene dosage effects in chronic lymphocytic leukemia. Cancer Genet Cytogenet 2010;203:149-60. [PMID: 21156227 DOI: 10.1016/j.cancergencyto.2010.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
42 Geisler C, Jurlander J, Bullinger L, Sander S, Brown P, Benner A, Philip P, Döhner H, Stilgenbauer S; for the Danish CLL-2 study group. Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemia. European Journal of Haematology 2009;83:156-8. [DOI: 10.1111/j.1600-0609.2009.01258.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
43 Hungermann D, Schmidt H, Natrajan R, Tidow N, Poos K, Reis-Filho JS, Brandt B, Buerger H, Korsching E. Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer. J Pathol 2011;224:517-28. [PMID: 21706489 DOI: 10.1002/path.2938] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
44 Staaf J, Jönsson G, Ringnér M, Vallon-Christersson J, Grabau D, Arason A, Gunnarsson H, Agnarsson BA, Malmström PO, Johannsson OT, Loman N, Barkardottir RB, Borg A. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer. Breast Cancer Res 2010;12:R25. [PMID: 20459607 DOI: 10.1186/bcr2568] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 8.3] [Reference Citation Analysis]
45 Ng CK, Martelotto LG, Gauthier A, Wen HC, Piscuoglio S, Lim RS, Cowell CF, Wilkerson PM, Wai P, Rodrigues DN. Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification. Genome Biol. 2015;16:107. [PMID: 25994018 DOI: 10.1186/s13059-015-0657-6] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 11.0] [Reference Citation Analysis]
46 Davis LK, Meyer KJ, Rudd DS, Librant AL, Epping EA, Sheffield VC, Wassink TH. Novel copy number variants in children with autism and additional developmental anomalies. J Neurodev Disord 2009;1:292-301. [PMID: 21547721 DOI: 10.1007/s11689-009-9013-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
47 van der Veken LT, Buijs A. Array CGH in human leukemia: from somatics to genetics. Cytogenet Genome Res 2011;135:260-70. [PMID: 21893961 DOI: 10.1159/000330629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
48 Koshy J, Qian Y, Bhagwath G, Willis M, Kelley TW, Papenhausen P. Microarray, gene sequencing, and reverse transcriptase–polymerase chain reaction analyses of a cryptic PML-RARA translocation. Cancer Genetics 2012;205:537-40. [DOI: 10.1016/j.cancergen.2012.07.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
49 Forsberg LA, Rasi C, Razzaghian HR, Pakalapati G, Waite L, Thilbeault KS, Ronowicz A, Wineinger NE, Tiwari HK, Boomsma D, Westerman MP, Harris JR, Lyle R, Essand M, Eriksson F, Assimes TL, Iribarren C, Strachan E, O'Hanlon TP, Rider LG, Miller FW, Giedraitis V, Lannfelt L, Ingelsson M, Piotrowski A, Pedersen NL, Absher D, Dumanski JP. Age-related somatic structural changes in the nuclear genome of human blood cells. Am J Hum Genet 2012;90:217-28. [PMID: 22305530 DOI: 10.1016/j.ajhg.2011.12.009] [Cited by in Crossref: 126] [Cited by in F6Publishing: 118] [Article Influence: 12.6] [Reference Citation Analysis]
50 Wilkerson PM, Dedes KJ, Wetterskog D, Mackay A, Lambros MB, Mansour M, Frankum J, Lord CJ, Natrajan R, Ashworth A, Reis-filho JS. Functional characterization of EMSY gene amplification in human cancers: EMSY amplification, cisplatin and PARP inhibitors. J Pathol 2011;225:29-42. [DOI: 10.1002/path.2944] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
51 Sellmann L, Scholtysik R, de Beer D, Eisele L, Klein-hitpass L, Nückel H, Dührsen U, Dürig J, Röth A, Baerlocher GM. Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 2015;57:590-5. [DOI: 10.3109/10428194.2015.1076929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
52 Chen M, Ye Y, Yang H, Tamboli P, Matin S, Tannir NM, Wood CG, Gu J, Wu X. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer 2009;125:2342-8. [PMID: 19521957 DOI: 10.1002/ijc.24642] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
53 Wineinger NE, Kennedy RE, Erickson SW, Wojczynski MK, Bruder CE, Tiwari HK. Statistical issues in the analysis of DNA Copy Number Variations. Int J Comput Biol Drug Des 2008;1:368-95. [PMID: 19774103 DOI: 10.1504/IJCBDD.2008.022208] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
54 Wan J, Gao Y, Zhao X, Wu Q, Fu X, Shao Y, Yang H, Guan M, Yu B, Zhang W. The association between the copy-number variations of ZMAT4 and hematological malignancy. Hematology 2011;16:20-3. [PMID: 21269563 DOI: 10.1179/102453311X12902908411751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Improgo MR, Brown JR. Genomic approaches to chronic lymphocytic leukemia. Hematol Oncol Clin North Am 2013;27:157-71. [PMID: 23561468 DOI: 10.1016/j.hoc.2013.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Chu F, Feng Q, Qian Y, Zhang C, Fang Z, Shen G. ERBB2 gene amplification in oral squamous cell malignancies: a correlation with tumor progression and gene expression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:90-5. [PMID: 21531597 DOI: 10.1016/j.tripleo.2011.01.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
57 Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, Jurlander J, Campo E, Juliusson G, Montserrat E, Smedby KE, Dyer MJ, Matutes E, Dearden C, Sunter NJ, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Parker A, Oscier D, Allan JM, Catovsky D, Houlston RS. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 2010;42:132-6. [PMID: 20062064 DOI: 10.1038/ng.510] [Cited by in Crossref: 179] [Cited by in F6Publishing: 160] [Article Influence: 14.9] [Reference Citation Analysis]
58 Shiu KK, Wetterskog D, Mackay A, Natrajan R, Lambros M, Sims D, Bajrami I, Brough R, Frankum J, Sharpe R, Marchio C, Horlings H, Reyal F, van der Vijver M, Turner N, Reis-Filho JS, Lord CJ, Ashworth A. Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies. Oncogene 2014;33:619-31. [PMID: 23334330 DOI: 10.1038/onc.2012.625] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
59 Guan M, Liu L, Zhao X, Wu Q, Yu B, Shao Y, Yang H, Fu X, Wan J, Zhang W. Copy number variations of EphA3 are associated with multiple types of hematologic malignancies. Clin Lymphoma Myeloma Leuk 2011;11:50-3. [PMID: 21454190 DOI: 10.3816/CLML.2011.n.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
60 Kresse SH, Szuhai K, Barragan-Polania AH, Rydbeck H, Cleton-Jansen AM, Myklebost O, Meza-Zepeda LA. Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours. BMC Res Notes 2010;3:223. [PMID: 20691109 DOI: 10.1186/1756-0500-3-223] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
61 Kaderi MA, Mansouri M, Zainuddin N, Cahill N, Gunnarsson R, Jansson M, Kimby E, Åleskog A, Lundin J, Glimelius B, Melbye M, Juliusson G, Jurlander J, Rosenquist R. Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia. Leukemia Research 2010;34:335-9. [DOI: 10.1016/j.leukres.2009.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
62 Codony C, Crespo M, Abrisqueta P, Montserrat E, Bosch F. Gene expression profiling in chronic lymphocytic leukaemia. Best Practice & Research Clinical Haematology 2009;22:211-22. [DOI: 10.1016/j.beha.2009.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
63 Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK, Thompson C, Phillips K, Rassenti LZ, Kipps TJ, Neuberg D, Freedman AS, Lee C, Brown JR. Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization. Br J Haematol 2010;151:336-45. [PMID: 20812997 DOI: 10.1111/j.1365-2141.2010.08341.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
64 Salgado R, Servitje O, Gallardo F, Vermeer MH, Ortiz-romero PL, Karpova MB, Zipser MC, Muniesa C, García-muret MP, Estrach T, Salido M, Sánchez-schmidt J, Herrera M, Romagosa V, Suela J, Ferreira BI, Cigudosa JC, Barranco C, Serrano S, Dummer R, Tensen CP, Solé F, Pujol RM, Espinet B. Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides. Journal of Investigative Dermatology 2010;130:1126-35. [DOI: 10.1038/jid.2009.306] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
65 Zhang C, Fang Z, Xiong Y, Li J, Liu L, Li M, Zhang W, Wan J. Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression. Acta Biochimica et Biophysica Sinica 2010;42:834-8. [DOI: 10.1093/abbs/gmq088] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
66 Staaf J, Isaksson S, Karlsson A, Jönsson M, Johansson L, Jönsson P, Botling J, Micke P, Baldetorp B, Planck M. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma. Int J Cancer 2013;132:2020-31. [PMID: 23023297 DOI: 10.1002/ijc.27879] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
67 Geyer FC, de Biase D, Lambros MBK, Ragazzi M, Lopez-garcia MA, Natrajan R, Mackay A, Kurelac I, Gasparre G, Ashworth A, Eusebi V, Reis-filho JS, Tallini G. Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology. Breast Cancer Res Treat 2012;132:15-28. [DOI: 10.1007/s10549-011-1504-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
68 Fang Z, Xiong Y, Zhang C, Li J, Liu L, Li M, Zhang W, Wan J. Coexistence of copy number increases of ZNF217 and CYP24A1 in colorectal cancers in a Chinese population. Oncol Lett 2010;1:925-30. [PMID: 22966406 DOI: 10.3892/ol_00000163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
69 Zhang J, Gao Y, Zhao X, Guan M, Zhang W, Wan J, Yu B. Investigation of copy-number variations of C8orf4 in hematological malignancies. Med Oncol 2011;28 Suppl 1:S647-52. [PMID: 20878554 DOI: 10.1007/s12032-010-9698-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
70 Schultz RA, Delioukina M, Gaal K, Bedell V, Smith DD, Forman SJ, McDaniel LD, Ballif BC, Shaffer LG, Slovak ML. Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis. Mol Cytogenet 2011;4:4. [PMID: 21291569 DOI: 10.1186/1755-8166-4-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
71 Möllerström E, Delle U, Danielsson A, Parris T, Olsson B, Karlsson P, Helou K. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer. Cancer Genet Cytogenet 2010;198:79-89. [PMID: 20362222 DOI: 10.1016/j.cancergencyto.2009.12.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
72 Wetterskog D, Lopez-Garcia MA, Lambros MB, A’Hern R, Geyer FC, Milanezi F, Cabral MC, Natrajan R, Gauthier A, Shiu KK. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol. 2012;226:84-96. [PMID: 22015727 DOI: 10.1002/path.2974] [Cited by in Crossref: 111] [Cited by in F6Publishing: 92] [Article Influence: 10.1] [Reference Citation Analysis]
73 Yang H, Zhang C, Zhao X, Wu Q, Fu X, Yu B, Shao Y, Guan M, Zhang W, Wan J, Huang X. Analysis of copy number variations of BS69 in multiple types of hematological malignancies. Ann Hematol 2010;89:959-64. [DOI: 10.1007/s00277-010-0966-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
74 Craddock KJ, Lam WL, Tsao M. Applications of Array-CGH for Lung Cancer. In: Banerjee D, Shah SP, editors. Array Comparative Genomic Hybridization. Totowa: Humana Press; 2013. pp. 297-324. [DOI: 10.1007/978-1-62703-281-0_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
75 Forsberg LA, Absher D, Dumanski JP. Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. J Med Genet 2013;50:1-10. [PMID: 23172682 DOI: 10.1136/jmedgenet-2012-101322] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
76 Staaf J, Borg Å. Zoom-In Array Comparative Genomic Hybridization (aCGH) to Detect Germline Rearrangements in Cancer Susceptibility Genes. In: Webb M, editor. Cancer Susceptibility. Totowa: Humana Press; 2010. pp. 221-35. [DOI: 10.1007/978-1-60761-759-4_13] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
77 Alsolami R, Knight SJ, Schuh A. Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia? Per Med 2013;10:361-76. [PMID: 24611071 DOI: 10.2217/pme.13.33] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
78 Kaderi MA, Kanduri M, Buhl AM, Sevov M, Cahill N, Gunnarsson R, Jansson M, Smedby KE, Hjalgrim H, Jurlander J, Juliusson G, Mansouri L, Rosenquist R. LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 2011;96:1153-60. [PMID: 21508119 DOI: 10.3324/haematol.2010.039396] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
79 Zainuddin N, Murray F, Kanduri M, Gunnarsson R, Smedby KE, Enblad G, Jurlander J, Juliusson G, Rosenquist R. TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia. Leuk Res 2011;35:272-4. [PMID: 20870288 DOI: 10.1016/j.leukres.2010.08.023] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
80 Shiu KK, Natrajan R, Geyer FC, Ashworth A, Reis-Filho JS. DNA amplifications in breast cancer: genotypic-phenotypic correlations. Future Oncol 2010;6:967-84. [PMID: 20528234 DOI: 10.2217/fon.10.56] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
81 Gorringe KL, Campbell IG. Large-scale genomic analysis of ovarian carcinomas. Mol Oncol 2009;3:157-64. [PMID: 19383377 DOI: 10.1016/j.molonc.2008.12.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
82 Staaf J, Vallon-Christersson J, Lindgren D, Juliusson G, Rosenquist R, Höglund M, Borg A, Ringnér M. Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios. BMC Bioinformatics 2008;9:409. [PMID: 18831757 DOI: 10.1186/1471-2105-9-409] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 7.0] [Reference Citation Analysis]
83 Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, Mackay A, Ashworth A, Reis-Filho JS. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol. 2010;220:562-573. [PMID: 20099298 DOI: 10.1002/path.2675] [Cited by in Crossref: 148] [Cited by in F6Publishing: 123] [Article Influence: 12.3] [Reference Citation Analysis]
84 Natrajan R, Lambros MB, Geyer FC, Marchio C, Tan DS, Vatcheva R, Shiu KK, Hungermann D, Rodriguez-Pinilla SM, Palacios J. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype? Genes Chromosomes Cancer. 2009;48:351-365. [PMID: 19156836 DOI: 10.1002/gcc.20646] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
85 Natrajan R, Mackay A, Wilkerson PM, Lambros MB, Wetterskog D, Arnedos M, Shiu KK, Geyer FC, Langerød A, Kreike B, Reyal F, Horlings HM, van de Vijver MJ, Palacios J, Weigelt B, Reis-Filho JS. Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Res 2012;14:R53. [PMID: 22433433 DOI: 10.1186/bcr3154] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
86 Li Z, Fang ZY, Ding Y, Yao WT, Yang Y, Zhu ZQ, Wang W, Zhang QX. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population. World J Gastroenterol 2012; 18(8): 855-860 [PMID: 22371647 DOI: 10.3748/wjg.v18.i8.855] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
87 Duprez R, Wilkerson PM, Lacroix-Triki M, Lambros MB, MacKay A, A'Hern R, Gauthier A, Pawar V, Colombo PE, Daley F, Natrajan R, Ward E, MacGrogan G, Arbion F, Michenet P, Weigelt B, Vincent-Salomon A, Reis-Filho JS. Immunophenotypic and genomic characterization of papillary carcinomas of the breast. J Pathol 2012;226:427-41. [PMID: 22025283 DOI: 10.1002/path.3032] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
88 Kanduri M, Cahill N, Göransson H, Enström C, Ryan F, Isaksson A, Rosenquist R. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 2010;115:296-305. [PMID: 19897574 DOI: 10.1182/blood-2009-07-232868] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 7.5] [Reference Citation Analysis]
89 Sutphin BS, Boczek NJ, Barajas-Martínez H, Hu D, Ye D, Tester DJ, Antzelevitch C, Ackerman MJ. Molecular and Functional Characterization of Rare CACNA1C Variants in Sudden Unexplained Death in the Young. Congenit Heart Dis 2016;11:683-92. [PMID: 27218670 DOI: 10.1111/chd.12371] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
90 Cooley LD, Lebo M, Li MM, Slovak ML, Wolff DJ; A Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee. American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders. Genet Med 2013;15:484-94. [DOI: 10.1038/gim.2013.49] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
91 Cahill N, Bergh A, Kanduri M, Göransson-kultima H, Mansouri L, Isaksson A, Ryan F, Smedby KE, Juliusson G, Sundström C, Rosén A, Rosenquist R. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013;27:150-8. [DOI: 10.1038/leu.2012.245] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 8.3] [Reference Citation Analysis]
92 Martinho O, Longatto-Filho A, Lambros MB, Martins A, Pinheiro C, Silva A, Pardal F, Amorim J, Mackay A, Milanezi F, Tamber N, Fenwick K, Ashworth A, Reis-Filho JS, Lopes JM, Reis RM. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br J Cancer 2009;101:973-82. [PMID: 19707201 DOI: 10.1038/sj.bjc.6605225] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
93 Gunnarsson R, Isaksson A, Mansouri M, Göransson H, Jansson M, Cahill N, Rasmussen M, Staaf J, Lundin J, Norin S, Buhl AM, Smedby KE, Hjalgrim H, Karlsson K, Jurlander J, Juliusson G, Rosenquist R. Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients. Leukemia 2010;24:211-5. [DOI: 10.1038/leu.2009.187] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
94 Staaf J, Jönsson G, Ringnér M, Baldetorp B, Borg A. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer. Breast Cancer Res 2011;13:R129. [PMID: 22169037 DOI: 10.1186/bcr3075] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
95 Klingbeil P, Natrajan R, Everitt G, Vatcheva R, Marchio C, Palacios J, Buerger H, Reis-Filho JS, Isacke CM. CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Res Treat. 2010;120:95-109. [PMID: 19350388 DOI: 10.1007/s10549-009-0380-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
96 Horlings HM, Weigelt B, Anderson EM, Lambros MB, Mackay A, Natrajan R, Ng CK, Geyer FC, van de Vijver MJ, Reis-Filho JS. Genomic profiling of histological special types of breast cancer. Breast Cancer Res Treat. 2013;142:257-269. [PMID: 24162157 DOI: 10.1007/s10549-013-2740-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
97 Chun K, Wenger GD, Chaubey A, Dash D, Kanagal-shamanna R, Kantarci S, Kolhe R, Van Dyke DL, Wang L, Wolff DJ, Miron PM. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genetics 2018;228-229:236-50. [DOI: 10.1016/j.cancergen.2018.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]